Skip to content

A UK study exploring whether the BabblePlay app can support early vocalising in infants with Down syndrome

A UK-based Randomised Controlled Trial of the BabblePlay app intervention to encourage vocalising in infants with Down syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN12366576
Enrollment
100
Registered
2026-01-13
Start date
2025-09-24
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Down syndrome Genetic Diseases

Interventions

The study is a two-arm, parallel-group, individually Randomised Controlled Trial (RCT) designed to evaluate the effectiveness of the BabblePlay app in supporting early vocal development in infants wit

Sponsors

University of York
Lead Sponsor

Eligibility

Sex/Gender
All
Age
7 Months to 15 Months

Inclusion criteria

Inclusion criteria: 1. The infant has a diagnosis of Down syndrome 2. The infant is aged between 7 and 15 months at the point of randomisation 3. The infant is growing up in a monolingual English-speaking household, or is exposed to less than 10% of another language, based on caregiver report 4. The infant has eyesight good enough to view shapes on an iPad screen (based on caregiver report) 5. Twins (triplets/quadruplets/….) are eligible to participate 6. The family is based in the UK 7. The infant is not taking part in another speech, language or communication intervention research study

Exclusion criteria

Exclusion criteria: 1. Infant does not meet the diagnosis, age, language exposure, or residency requirements listed above 2. Infant has visual difficulties that would prevent them from seeing shapes on the iPad screen 3. Infant is currently participating in another speech, language, or communication intervention research study

Countries

England, United Kingdom

Contacts

Public ContactTamar;Laura Keren-Portnoy;Boundy

;

tamar.keren-portnoy@york.ac.uk;laura.boundy@york.ac.uk+44 (0)1904 323614;N/A

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026